Two of the leading developers of Car-T immuno-oncology drugs, Imugene and Chimeric have unveiled further positive trial ...

In the world of decentralized finance, few projects have captured early-stage momentum like Toncoin (TON). But now, a new protocol is emerging with a more refined foundation and future-ready ...

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies ...

Lionel Messi exited Inter Miami’s Leagues Cup game against Necaxa in the 11th minute after a stretch of 30 games for Miami with 18 goals and nine assists.

The first section of the water distribution ring pipe was recently installed in the machine pit at the Datang Zala Hydropower ...

THE Shanghai Masters snooker 2025 final is UNDERWAY – and there is a whopping £210k up for grabs. The unseeded Ali Carter ...

If you're looking to put cash into two fantastic biotech stocks that Wall Street seems particularly bullish on, there's one ...

This move follows a strategic agreement signed during last year’s Cityscape global exhibition in Riyadh and represents a ...

Union Home and Urban Affairs Minister Manohar Lal Khattar confirmed on X, “I am pleased to announce that the Hon’ble Prime ...

The Ministry of Health and Prevention (MoHAP) announced it has successfully redesigned and restructured a series of key ...

Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China's Class 1 pathway for innovative drugs.

Compass Pathways fell on Phase 3 data but remains on track for an FDA filing despite dilution risks and volatility. Find out ...